Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Retrospective genetic testing (Traceback) in women with early-onset breast cancer after revised national guidelines: a clinical implementation study.

Breast cancer research and treatment - 1 Jun 2024

Augustinsson Annelie, Loman Niklas, Ehrencrona Hans

Abstract excerpt

PURPOSE: This study focused on identifying a hereditary predisposition in women previously diagnosed with early-onset breast cancer through a retrospective outreach activity (Traceback). The objectives were to evaluate the possible clinical implementation of a simplified Traceback strategy and to identify carriers of pathogenic variants among previously untested women. METHODS: Three hundred and fifteen...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age of Onset
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Counseling

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Mutation

Share to Practice Guidelines as Topic

Share to Sweden

Source

Open in PubMed Open full text

Identifiers

PMID: 38491334
DOI: 10.1007/s10549-024-07288-9
PMCID: PMC11101361

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Retrospective genetic testing (Traceback) in women with early-onset breast cancer after revised national guidelines: a clinical implementation study.PMID 38491334Read ↗

Genetic testing in women with early-onset breast cancer: a Traceback pilot study.Semantic proximity Read ↗

Genetic counseling and genetic testing for pathogenic germline mutations among high-risk patients previously diagnosed with breast cancer: a traceback approach.Semantic proximity Read ↗

Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based OutreachSemantic proximity Read ↗

Clinical Implementation Study of Genetic Risk-Based Breast Cancer Screening.Semantic proximity Read ↗

Uptake of Risk-Reducing Measures, Cascade Testing, and Related Challenges Among Carriers of Breast Cancer-Associated Germline Pathogenic Variants in Mexico.Semantic proximity Read ↗

TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members.Semantic proximity Read ↗

Routine germline genetic testing in 3552 unselected NHS breast cancer patients: Evidence informing testing criteria and implementation of a ‘BRCA-DIRECT’ mainstreaming pathwaySemantic proximity Read ↗

Penetrance of breast cancer genes from the eMERGE III NetworkSemantic proximity Read ↗

Uptake of Cascade Genetic Testing for Hereditary Breast Cancer in the Public Health System in a Middle-Income Country: A Real-World Study.Semantic proximity Read ↗

An implementation study of the service model for genetic risk-based stratified breast cancer screening – Estonian results of the BRIGHT projectSemantic proximity Read ↗

BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trial.Semantic proximity Read ↗

Patient uptake of updated genetic testing following uninformative BRCA1 and BRCA2 results.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.